-
cds.ahrq.gov/sites/default/files/workgroups/143366/CDS_Connect_WG_April_2022_Summary.pdf
January 01, 2022 - April 2022 CDS Connect Work Group Summary
Clinical Decision Support (CDS) Connect Work Group (WG)
Meeting Summary
April 21, 2022
3:00 – 4:00 pm ET
Attendees: 31 people, including 6 phone dial-ins
Organization Attendees
AHRQ Sponsors Edwin Lomatan, Mario Teran, Roland Gamache (3)
WG Members Alex Go…
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository.pdf
September 21, 2018 - ▪ See contact info on the next slide
– If interested, thoughts captured in a Word document or scratchpad
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository_0.pdf
September 21, 2018 - ▪ See contact info on the next slide
– If interested, thoughts captured in a Word document or scratchpad
-
cds.ahrq.gov/sites/default/files/workgroups/2246/CDS_Connect_WG_May_2021_Summary.pdf
January 01, 2021 - Step 4: Optimize Support for Implementers
MITRE asked WG members for other thoughts related to the
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Pilot%20Report_Final_0.docx
March 01, 2018 - that it did to some extent, but felt that ultimately, CDS, and the pilot CDS specifically, was best thought … Data Sharing
When asked for thoughts as to what conditions and data elements needed to be better shared
-
cds.ahrq.gov/sites/default/files/reports/AHRQ_Final_Report_2017.pdf
January 01, 2017 - Focus group
questions focused on the clinician experience with the CDS, their thoughts on the clinical
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
October 01, 2017 - Aligns with ACC/AHA thoughts on contraindications for statin use.
-
cds.ahrq.gov/sites/default/files/cds/artifact/1071/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - than 70
percent of respondents found the information easy to understand, and more than 55 percent
thought
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - than 70
percent of respondents found the information easy to understand, and more than 55 percent
thought
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - than 70
percent of respondents found the information easy to understand, and more than 55 percent
thought
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - than 70
percent of respondents found the information easy to understand, and more than 55 percent
thought
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - than 70
percent of respondents found the information easy to understand, and more than 55 percent
thought
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2019%20CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
January 01, 2019 - than 70
percent of respondents found the information easy to understand, and more than 55 percent
thought
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2020.pdf
January 01, 2020 - The four sessions in which the team participated were well attended and evoked thought-
provoking questions
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2019.pdf
January 01, 2019 - than 70 percent of respondents found the information easy to
understand, and more than 55 percent thought
-
cds.ahrq.gov/sites/default/files/reports/AHRQ_Final_Report_2018.pdf
January 01, 2018 - Questions and
discussion focused on the clinicians’ experience with the CDS, their thoughts on the clinical
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository.xlsx
January 01, 2003 - 200 MG Extended Release Oral Capsule 1491529 Indomethacin 40 MG Oral Capsule F42.2 Mixed obsessional thoughts
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
January 01, 2003 - 200 MG Extended Release Oral Capsule 1491529 Indomethacin 40 MG Oral Capsule F42.2 Mixed obsessional thoughts